Oct 2026· Journal of Histochemistry and Cytochemistry· pp.
221554261478977
· 0 citations· 57 references
Medicine
TL;DR
Evaluated RPCs isolated from PND12-PND15 Wistar rat pups obtained from age-matched breeding pairs assess their pluripotency and regenerative capacity in vivo and pilot data indicate enhanced potential of these cells in promoting retinal ganglion layer repair.
Abstract
Retinal precursor cells (RPCs) derived from embryonic, mesenchymal, induced pluripotent, and neonatal sources have demonstrated significant potential in cell replacement therapies for retinal degeneration. Early postnatal RPCs (PND0-PND8) can integrate into the adult diseased retina; however, their limited survival reduces long-term therapeutic efficacy. In contrast, RPCs from later neonatal stages (>PND15), being more lineage-committed, may yield improved regenerative outcomes, particularly for Müller glia and photoreceptors. In this study, we evaluated RPCs isolated from PND12-PND15 Wistar rat pups obtained from age-matched breeding pairs to assess their pluripotency and regenerative capacity in vivo. A modified protocol incorporating EDTA in nuclease-free buffers was standardized for retinal dissection, processing, and incubation, followed by culture in neurobasal medium supplemented with B27 and FGF2. Undifferentiated neurospheres expressing stem cell markers Nanog and Sox2 were dissociated at 96 hr and transplanted into an adult N-methyl-d-aspartate-induced retinal degeneration model. Compared with early postnatal RPCs (PND2-PND4), which formed smaller, slow-growing neurospheres (2.58 ± 0.15 µm) with rapid differentiation, PND12-PND15 RPCs generated larger, stable neurospheres (4.5 ± 0.18 µm) within 48 hr. Pilot data indicate enhanced potential of these cells in promoting retinal ganglion layer repair.
Direct reprogramming of glial progenitor cells (GPCs) into induced neurons (iNs) represents a promising strategy for future brain regenerative therapies. This approach uses forced expression of neuronal fate-determining genes to convert non-neuronal cells into neurons, bypassing a pluripotent intermediate stage and ena...
E. Cepeda-Prado, Gianluigi Nocera, Christina-Anastasia Stamouli et al.· Neurobiology of Disease· 0 citations
This study establishes a cost- and time-efficient approach for generating functional OLs from iPSCs, with broad applicability for disease modeling, drug screening, and the development of regenerative therapies.
I. Bienjonetti, Vincent Roy, M. Beaudet et al.· Journal of Neuroscience Rese...· 0 citations
It appears that human midgestation retina development is mirrored in the first 2 weeks of mouse postnatal development, closing a gap in the literature concerning the correlation between human and mouse retinal maturation timelines.
Raluca Pașcalău, R. Ciortea, Diana Petre et al.· The Journal of comparative n...· 0 citations
Induced pluripotent stem cell (iPSC)-derived retinal organoids (ROs) have emerged as a platform for photoreceptor replacement therapy, supported by two complementary approaches: cone precursor cell transplantation and RO transplantation. Both have demonstrated proof of concept for functional synaptic integration with t...
Abstract Oligodendrocytes facilitate saltatory conduction and they support both neuronal and axonal survival; thus, when they are diseased or damaged, neurological problems ensue. Oligodendrocyte progenitors (OPCs) have been successfully isolated from rodents using magnetic beads, immunopanning and differential adhesio...
Lisamarie Moore, Lauren E. McLane, Stacey E. Wahl et al.· ASN Neuro· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.